Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) has been fighting cancer cells with immune cells for more than 120 years. Researchers across disciplines including immunologists, geneticists and cell biologists work together to make groundbreaking developments. They create powerful immune therapies, focusing on checkpoint inhibitors and CAR-T cell therapy, to treat various forms of advanced cancer. PICI researchers at MSK push the boundaries in cancer research – not only to improve existing immunotherapies but open doors to new ones.

Jedd Wolchok, MD, PhD | Director
Marcel van den Brink, MD, PhD | Co-Director